Physicians' Academy for Cardiovascular Education
PACE-CME.org was present at the ESC 2018 in Munich, Germany. Find coverage of the latest CV news on PACE-CME.
Prof. Ference shows that PCSK9 inhibition has biologically and therapeutically equivalent effects on the risk of CVD as observed with statins.
ESC 2018 The benefit of sacubitril/valsartan in HFrEF is not subject to debate, but opinions do vary on when to use it. An impression of the arguments on whether or not it should be the starting treatment.
ESC 2018 In a randomized trial treatment with tafamidis resulted in impressive, significant reduced mortality and hospitality due to CV events in patients with ATTR-CM and HF.
ESC 2018 Dr Allard-Ratick shares the surprising result that HDL-C levels >60 mg/dl (1.5 mmol/L) were associated with a nearly two-fold increase in the risk of CV death or MI in adults with CV disease.
ESC 2018 In one of this year’s organized debates, it was discussed how the COMPASS trial results should or should not change clinical practice; an impression of the arguments of both sides.
ESC 2018 The TRANSITION study results show that sacubitril/valsartan was safe and well-tolerated in a wide range of HFrEF patients who have been stabilized after an acute HF episode , showing CV safety.
ESC 2018 The NHANES cohort study showed that low-carbohydrate diets increase the risk of mortality in adults, a finding that was validated by a meta-analysis of pooled prospective cohort studies.
ESC 2018 In adults with CV disease, HDL-C levels >60 mg/dl (1.5 mmol/L) were associated with a nearly two-fold increase in the risk of CV death or MI.
ESC 2018 Results of the VERDICT trial were neutral for an early intervention strategy compared to standard management in NSTEMI patients. However, a beneficial effect of early intervention was observed in those with a GRACE score >140.
ESC 2018 Prof Mills discusses the results of a high-sensitivity troponin test for the diagnosis of MI on outcomes in the High-STEACS trial and gives explanations for the unexpected results.
ESC 2018 In an analysis of four large global studies, higher healthy diet score was related to a lower risk of mortality, MI and stroke. Dr. Mente discusses how the healthy diet score is calculated and talks about the results of these four studies.
ESC 2018 The PURE cohort study and three other studies showed reduced risk of CV disease and mortality with higher healthy diet score in general populations worldwide.
